vs
Side-by-side financial comparison of C & F FINANCIAL CORP (CFFI) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
C & F FINANCIAL CORP is the larger business by last-quarter revenue ($35.9M vs $20.4M, roughly 1.8× Sight Sciences, Inc.). C & F FINANCIAL CORP runs the higher net margin — 18.7% vs -20.4%, a 39.1% gap on every dollar of revenue. On growth, C & F FINANCIAL CORP posted the faster year-over-year revenue change (12.0% vs 6.9%). C & F FINANCIAL CORP produced more free cash flow last quarter ($22.2M vs $-2.0M). Over the past eight quarters, C & F FINANCIAL CORP's revenue compounded faster (8.2% CAGR vs 2.9%).
Sun Life Financial Inc. is a Canadian financial services company headquartered in Toronto, Ontario. Founded in 1865, it operates internationally in life insurance, wealth management, and asset management. As of 2024, the company manages over CAD$1.3 trillion in assets and serves clients in Canada, the United States, Asia, and other markets.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
CFFI vs SGHT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $35.9M | $20.4M |
| Net Profit | $6.7M | $-4.2M |
| Gross Margin | — | 87.3% |
| Operating Margin | 22.6% | -18.0% |
| Net Margin | 18.7% | -20.4% |
| Revenue YoY | 12.0% | 6.9% |
| Net Profit YoY | 11.0% | 64.9% |
| EPS (diluted) | $2.08 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $35.9M | $20.4M | ||
| Q3 25 | $36.0M | $19.9M | ||
| Q2 25 | $36.4M | $19.6M | ||
| Q1 25 | $32.6M | $17.5M | ||
| Q4 24 | $32.0M | $19.1M | ||
| Q3 24 | $33.5M | $20.2M | ||
| Q2 24 | $31.2M | $21.4M | ||
| Q1 24 | $30.6M | $19.3M |
| Q4 25 | $6.7M | $-4.2M | ||
| Q3 25 | $7.1M | $-8.2M | ||
| Q2 25 | $7.7M | $-11.9M | ||
| Q1 25 | $5.4M | $-14.2M | ||
| Q4 24 | $6.0M | $-11.8M | ||
| Q3 24 | $5.4M | $-11.1M | ||
| Q2 24 | $5.0M | $-12.3M | ||
| Q1 24 | $3.4M | $-16.3M |
| Q4 25 | — | 87.3% | ||
| Q3 25 | — | 86.4% | ||
| Q2 25 | — | 84.8% | ||
| Q1 25 | — | 86.2% | ||
| Q4 24 | — | 86.8% | ||
| Q3 24 | — | 83.9% | ||
| Q2 24 | — | 85.8% | ||
| Q1 24 | — | 85.5% |
| Q4 25 | 22.6% | -18.0% | ||
| Q3 25 | 24.5% | -39.7% | ||
| Q2 25 | 26.5% | -59.6% | ||
| Q1 25 | 20.0% | -79.2% | ||
| Q4 24 | 22.6% | -62.5% | ||
| Q3 24 | 19.9% | -55.7% | ||
| Q2 24 | 20.0% | -59.2% | ||
| Q1 24 | 13.1% | -76.4% |
| Q4 25 | 18.7% | -20.4% | ||
| Q3 25 | 19.6% | -41.0% | ||
| Q2 25 | 21.2% | -61.0% | ||
| Q1 25 | 16.5% | -80.8% | ||
| Q4 24 | 18.8% | -62.1% | ||
| Q3 24 | 16.1% | -54.9% | ||
| Q2 24 | 16.1% | -57.7% | ||
| Q1 24 | 11.1% | -84.4% |
| Q4 25 | $2.08 | $-0.07 | ||
| Q3 25 | $2.18 | $-0.16 | ||
| Q2 25 | $2.37 | $-0.23 | ||
| Q1 25 | $1.66 | $-0.28 | ||
| Q4 24 | $1.85 | $-0.23 | ||
| Q3 24 | $1.65 | $-0.22 | ||
| Q2 24 | $1.50 | $-0.25 | ||
| Q1 24 | $1.01 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $92.0M |
| Total DebtLower is stronger | — | $42.4M |
| Stockholders' EquityBook value | $261.8M | $63.9M |
| Total Assets | $2.8B | $115.3M |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $92.0M | ||
| Q3 25 | — | $92.4M | ||
| Q2 25 | — | $101.5M | ||
| Q1 25 | — | $108.8M | ||
| Q4 24 | — | $120.4M | ||
| Q3 24 | — | $118.6M | ||
| Q2 24 | — | $118.2M | ||
| Q1 24 | — | $127.3M |
| Q4 25 | — | $42.4M | ||
| Q3 25 | — | $42.4M | ||
| Q2 25 | — | $42.4M | ||
| Q1 25 | — | $42.4M | ||
| Q4 24 | — | $40.0M | ||
| Q3 24 | — | $37.1M | ||
| Q2 24 | — | $35.0M | ||
| Q1 24 | — | $35.0M |
| Q4 25 | $261.8M | $63.9M | ||
| Q3 25 | $253.3M | $64.3M | ||
| Q2 25 | $240.3M | $70.0M | ||
| Q1 25 | $234.6M | $77.6M | ||
| Q4 24 | $226.4M | $87.5M | ||
| Q3 24 | $227.3M | $95.0M | ||
| Q2 24 | $218.5M | $101.6M | ||
| Q1 24 | $216.3M | $109.2M |
| Q4 25 | $2.8B | $115.3M | ||
| Q3 25 | $2.7B | $116.3M | ||
| Q2 25 | $2.7B | $122.0M | ||
| Q1 25 | $2.6B | $129.7M | ||
| Q4 24 | $2.6B | $142.8M | ||
| Q3 24 | $2.6B | $143.6M | ||
| Q2 24 | $2.5B | $149.7M | ||
| Q1 24 | $2.5B | $155.6M |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $24.5M | $-1.8M |
| Free Cash FlowOCF − Capex | $22.2M | $-2.0M |
| FCF MarginFCF / Revenue | 61.8% | -9.7% |
| Capex IntensityCapex / Revenue | 6.5% | 0.8% |
| Cash ConversionOCF / Net Profit | 3.65× | — |
| TTM Free Cash FlowTrailing 4 quarters | $42.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.5M | $-1.8M | ||
| Q3 25 | $23.4M | $-8.7M | ||
| Q2 25 | $-4.4M | $-7.5M | ||
| Q1 25 | $3.2M | $-11.6M | ||
| Q4 24 | $36.8M | $-3.5M | ||
| Q3 24 | $404.0K | $362.0K | ||
| Q2 24 | $1.7M | $-9.5M | ||
| Q1 24 | $895.0K | $-9.8M |
| Q4 25 | $22.2M | $-2.0M | ||
| Q3 25 | $22.7M | $-8.9M | ||
| Q2 25 | $-5.0M | $-7.8M | ||
| Q1 25 | $2.9M | — | ||
| Q4 24 | $33.3M | $-3.6M | ||
| Q3 24 | $-1.6M | $311.0K | ||
| Q2 24 | $1.2M | $-9.5M | ||
| Q1 24 | $410.0K | $-9.9M |
| Q4 25 | 61.8% | -9.7% | ||
| Q3 25 | 63.0% | -44.7% | ||
| Q2 25 | -13.6% | -39.6% | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 103.8% | -18.9% | ||
| Q3 24 | -4.9% | 1.5% | ||
| Q2 24 | 3.7% | -44.7% | ||
| Q1 24 | 1.3% | -51.4% |
| Q4 25 | 6.5% | 0.8% | ||
| Q3 25 | 2.1% | 0.9% | ||
| Q2 25 | 1.6% | 1.1% | ||
| Q1 25 | 0.8% | 0.0% | ||
| Q4 24 | 10.9% | 0.7% | ||
| Q3 24 | 6.1% | 0.3% | ||
| Q2 24 | 1.7% | 0.4% | ||
| Q1 24 | 1.6% | 0.6% |
| Q4 25 | 3.65× | — | ||
| Q3 25 | 3.31× | — | ||
| Q2 25 | -0.57× | — | ||
| Q1 25 | 0.60× | — | ||
| Q4 24 | 6.09× | — | ||
| Q3 24 | 0.07× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 0.26× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CFFI
| Community Banking | $25.9M | 72% |
| Consumer Finance Segment | $7.0M | 19% |
| Mortgage Banking Segment | $1.9M | 5% |
| Other | $1.1M | 3% |
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
